Pharmabiz2h
Study finds low oxygen during sleep and sleep apnoea linked to epilepsy in older adults
Sleep apnoea and low oxygen levels while sleeping are associated with epilepsy that first occurs after 60 years of age, known as late-onset epilepsy, according to a new study funded by the National ...
Pharmabiz9h
Pfizer & Genmab’s Tivdak receives US FDA full approval to treat recurrent or metastatic cervical cancer
Pfizer Inc. and Genmab A/S announced the US Food and Drug Administration (FDA) approves the supplemental Biologics License Application (sBLA) granting full approval for Tivdak (tisotumab vedotin-tftv) ...
Pharmabiz10h
OGT launches new SureSeq Myeloid Fusion Panel to help drive advances in myeloid cancer research
OGT launches new SureSeq Myeloid Fusion Panel to help drive advances in myeloid cancer research: Oxford, UK Thursday, May 2, 2024, 16:00 Hrs [IST] OGT, a leading global provider o ...
Pharmabiz10h
Sri Sathya Sai Sanjeevani Hospitals performs over 4,500 free paediatric cardiac surgeries under Ayushman Bharat Scheme
Sri Sathya Sai Sanjeevani Hospitals performs over 4,500 free paediatric cardiac surgeries under Ayushman Bharat Scheme: Our Bureau, Bengaluru Thursday, May 2, 2024, 15:45 Hrs [IST ...
Pharmabiz11h
US FDA approves Abbott's breakthrough dissolving stent, Esprit BTK System for people with CLTI below-the-knee
Abbott Park, Illinois Thursday, May 2, 2024, 15:00 Hrs [IST] ...
Pharmabiz10h
Indegene spots large addressable market in outsourcing and digitalisation to use its IPO proceeds
Indegene spots large addressable market in outsourcing and digitalisation to use its IPO proceeds: Our Bureau, Bengaluru Thursday, May 2, 2024, 16:15 Hrs [IST] Indegene is eyeing ...
Pharmabiz8h
KEA notifies D Pharm students lateral entry to 2nd year B Pharm; releases online document verification schedule
In a major move to support the pharmacy students concern, Karnataka Education Authority (KEA) has now notified on D Pharm (diploma in pharmacy) students lateral entry to 2nd year B Pharm. This follows ...
Pharmabiz3h
SeaStar Medical gets $3.6 million NIH grant to study Selective Cytopheretic Device in adult patients with severe CHF
SeaStar Medical Holding Corporation, a medical device company developing proprietary solutions to reduce the consequences of hyper inflammation on vital organs, announces that the National Institutes ...
Pharmabiz6h
ClearPoint Neuro receives US FDA 510(k) clearance for its Prism Bone Anchor Accessory
ClearPoint Neuro, Inc, a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, announced it has received 510(k) clearance for its Prism Bone Anchor ...
Pharmabiz12h
Lilavati Kirtilal Mehta Medical Trust Board expose major financial fraud amounting around Rs. 500 crore
Lilavati Kirtilal Mehta Medical Trust Board expose major financial fraud amounting around Rs. 500 crore: Our Bureau, Mumbai Thursday, May 2, 2024, 13:45 Hrs [IST] Prashant Mehta, ...
Pharmabiz10h
PeptiDream expands peptide discovery collaboration with Novartis
PeptiDream Inc., a public Kanagawa, Japan-based biopharmaceutical company announced an expansion of its peptide discovery collaboration with Swiss-based Novartis Pharma AG. Under the multi-programme ...
Pharmabiz9h
Donaldson Company inks agreement to acquire minority stake in Medica
Donaldson Company, Inc, a leading worldwide provider of innovative filtration products and solutions, announced it has entered into a definitive agreement allowing the Donaldson to purchase a 49 per ...